Digital PCR and qPCR Market by Technology, Product, End User, Application Global Forecast to 2019

The global digital PCR (dPCR) and qPCR market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, France, and U.K.) hold larger shares in the digital PCR (dPCR) and qPCR market, the Asia-Pacific region is expected to grow at the highest CAGR of ~10.7% in the forecast period. The growth of the digital PCR (dPCR) and qPCR market is driven by factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases and genetic disorders, and increased public-private investments, funds, and grants. However, factors such as high cost of dPCR instruments and limitations of qPCR and dPCR techniques are restraining the growth of this market. Attempts for adoption, implementation of MIQE guidelines for publishing qPCR and dPCR-based research is posing a significant challenge for the growth of the digital PCR (dPCR) and qPCR market.

In this report, the global digital PCR (dPCR) and qPCR market has been segmented on the basis of type of technology (real-time PCR and digital PCR), type of product (instruments, reagents and consumables, and softwares and services), type of end-users (research laboratories and academic institutes, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, clinical research organizations, and forensic laboratories) applications and type of application (research, clinical, and forensic applications). The real-time PCR (qPCR) technology market accounted for the largest share of the global digital PCR (dPCR) and qPCR market in 2014, followed by the digital PCR (dPCR) market. Factors such as technological advancements in the field of qPCR, rising adoption of qPCR in research and medical diagnosis, benefits offered by robotics in lab automation, and increasing installation base of qPCR instruments are driving the growth of qPCR technology market.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of 39.7% of the global digital PCR (dPCR) and qPCR market in 2014, followed by Europe. The digital PCR (dPCR) and qPCR market in the North America is primarily driven by factors such as increase in public and private funding for development of qPCR and dPCR technology, growing number of cancer patients, continuous reduction in average cost of gene sequencing, and presence of major pharmaceutical companies in the U.S. However, financial constraints faced by market players are limiting the growth of the digital PCR (dPCR) and qPCR market in this region. The Asia-Pacific region is poised to grow at the highest CAGR of 10.7% in the next five years, owing to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market, and strengthening cancer research in Japan.

The global digital PCR (dPCR) and qPCR market is highly competitive with a large number of global as well as local market players. As of 2013, the global digital PCR (dPCR) and qPCR market was dominated by Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), and F. Hoffmann-La Roche, Ltd. (Switzerland), which together accounted for ~70% of the market. New product launches, product enhancements, and partnerships, agreements, and collaborations are the major strategies adopted by most of the market players to achieve growth in the global digital PCR (dPCR) and qPCR market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis — industry analysis (industry trends and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the qPCR and dPCR market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on qPCR and dPCR products offered by the top 10 players in the global digital PCR (dPCR) and qPCR market. The report analyzes the digital PCR (dPCR) and qPCR market by type of product, technology, end-user, and application across key geographic region

‧ Product Development/Innovation: Detailed insights on upcoming qPCR and dPCR technologies, research and development activities, and new product launches in the global digital PCR (dPCR) and qPCR market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various qPCR and dPCR products across key geographic region

‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global digital PCR (dPCR) and qPCR market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global digital PCR (dPCR) and qPCR market

Table Of Contents

1 Introduction (Page No. - 20)
1.1 Study Objectives
1.2 Digital PCR and qPCR Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered For The Study
1.4 Currency And Pricing
1.5 Package Size
1.6 Limitations
1.7 Digital PCR and qPCR Market Stakeholders

2 Research Methodology (Page No. - 25)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown Of Primaries
2.2 Factor Analysis
2.2.1 Introduction
2.2.2 Demand-Side Analysis
2.2.2.1 Healthcare Expenditure Patterns
2.2.2.2 Rapid Growth Of Aging Population
2.2.2.3 Incidence And Prevalence Of Cancer
2.2.2.4 Birth Rate /Pregnancies
2.2.2.5 Burden Of Infectious Diseases
2.2.2.6 Number Of Clinical, Forensic, And Research Laboratories
2.2.3 Supply-Side Analysis
2.2.3.1 Number Of New Product Launches: qPCR And dPCR Vs. Competitive Technologies
2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
2.3 Digital PCR and qPCR Market Size Estimation
2.3.1 Top-Down Approach
2.3.2 Bottom-Up Approach
2.4 qPCR And Digital PCR Market Breakdown And Data Triangulation
2.5 Research Assumptions And Limitations
2.5.1 Assumptions
2.5.2 Limitations

3 Executive Summary (Page No. - 48)
3.1 Introduction
3.2 History, Evolution, And Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. - 54)
4.1 Attractive Market Opportunities In The qPCR And Digital PCR Market
4.2 Global qPCR And dPCR Technology Market, By Region (2014–2019)
4.3 Top 3 qPCR/dPCR Application Markets, By Region (2014)
4.4 Global qPCR And Digital PCR Market, By Product (2014–2019)
4.5 Global qPCR And Digital PCR Market, By End User (2014–2019)

5 Market Overview (Page No. - 59)
5.1 Introduction
5.2 Digital PCR and qPCR Market Segmentation
5.2.1 qPCR And Digital PCR Market, By Technology
5.2.2 qPCR And Digital PCR Market, By Product
5.2.3 qPCR And Digital PCR Market, By End User
5.2.4 qPCR And Digital PCR Market, By Application
5.3 Evolution
5.4 Digital PCR and qPCR Market Dynamics
5.4.1 Drivers
5.4.1.1 Growing Geriatric Population
5.4.1.2 Technological Advancements
5.4.1.3 Rising Incidence Of Infectious Diseases And Genetic Disorders
5.4.1.4 Increasing Public-Private Investments, Funds, And Grants
5.4.2 Restraints
5.4.2.1 High Cost Of dPCR Instruments
5.4.2.2 Limitations Of qPCR And dPCR Techniques
5.4.3 Opportunities
5.4.3.1 Successful Completion Of Human Genome Project
5.4.3.2 Growing Market Penetration In Emerging Countries
5.4.3.3 Shift From Plant-Derived To Genome-Based Drug Discovery
5.4.4 Challenges
5.4.4.1 Adoption, Implementation Miqe Guidelines For Publishing qPCR And dPCR-Based Research

6 Industry Trends (Page No. - 73)
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Technology Integration To Accelerate DNA Analysis Process
6.3.2 Development Of Lab-On-Chip PCR Devices
6.3.3 Advancements In Probe Technology To Enhance qPCR Sensitivity
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power Of Suppliers
6.4.4 Bargaining Power Of Buyers
6.4.5 Intensity Of Competitive Rivalry

7 Global qPCR And dPCR Market, By Technology (Page No. - 82)
7.1 Introduction
7.2 Quantitative PCR ( qPCR)
7.3 Digital PCR (dPCR)

8 Global qPCR And dPCR Market, By Product And Services (Page No. - 88)
8.1 Introduction
8.2 qPCR Products Market
8.2.1 qPCR Instruments Market
8.2.2 qPCR Reagents And Consumables Market
8.2.3 qPCR Software And Services Market
8.3 dPCR Products Market
8.3.1 dPCR Instruments Market
8.3.2 dPCR Reagents And Consumables Market
8.3.3 dPCR Software And Services Market

9 PCR And dPCR Market, By Application (Page No. - 101)
9.1 Introduction
9.2 Quantitative PCR ( qPCR)
9.2.1 Clinical Applications
9.2.2 Research Applications
9.2.3 Forensic Applications
9.3 Digital PCR (dPCR)
9.3.1 Clinical Applications
9.3.2 Research Applications
9.3.3 Forensic Applications

10 qPCR And dPCR Market, By End User (Page No. - 113)
10.1 Introduction
10.1.1 Research Laboratories And Academic Institutes
10.1.2 Pharmaceutical And Biotechnology Companies
10.1.3 Hospitals And Diagnostic Centers
10.1.4 Clinical Research Organizations
10.1.5 Forensic Laboratories

11 qPCR And dPCR Market, By Region (Page No. - 127)
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia-Pacific
11.5 Rest Of The World (ROW)

12 Competitive Landscape (Page No. - 146)
12.1 Overview
12.2 Digital PCR and qPCR Market Share Analysis, By Key Player, 2013
12.3 Competitive Scenario
12.4 Recent Developments
12.4.1 New Product Launches And Product Enhancements
12.4.2 Agreements, Partnerships, And Collaborations
12.4.3 Geographical Expansions
12.4.4 Mergers And Acquisitions
12.4.5 Other Developments

13 Company Profiles (Page No. - 157)
13.1 Introduction
13.1.1 Geographic Revenue Mix
13.1.2 Strategic Benchmarking
13.1.2.1 Technological Advancements And Product Enhancements
13.1.2.2 Entry Into Asia-Pacific Market
13.2 Agilent Technologies, Inc.
13.2.1 Business Overview
13.2.2 Products & Services
13.2.3 Key Strategies
13.2.4 Recent Developments
13.2.5 SWOT Analysis
13.3 Biomerieux Sa
13.3.1 Business Overview
13.3.2 Products & Services
13.3.3 Key Strategies
13.3.4 Recent Developments
13.4 Bio-Rad Laboratories, Inc.
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Key Strategies
13.4.4 Recent Developments
13.4.5 SWOT Analysis
13.5 Biosistemika, Research And Development Llc
13.5.1 Business Overview
13.5.2 Product Portfolio
13.6 Eppendorf Ag
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategies
13.6.4 Recent Developments
13.7 F. Hoffman-La Roche Ltd. (Switzerland)
13.7.1 Business Overview
13.7.2 Products & Services
13.7.3 Key Strategies
13.7.4 Recent Developments
13.7.5 SWOT Analysis
13.8 Fluidigm Corporation (U.S.)
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategies
13.8.4 Recent Developments
13.9 Qiagen N.V.
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategies
13.9.4 Recent Developments
13.9.5 SWOT Analysis
13.1 Raindance Technologies, Inc.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategies
13.10.4 Recent Developments
13.11 Takara Bio, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Key Strategies
13.11.4 Recent Developments
13.12 Thermo Fisher Scientific, Inc.
13.12.1 Business Overview
13.12.2 Products & Services
13.12.3 Key Strategies
13.12.4 Recent Developments
13.12.5 SWOT Analysis

14 Appendix (Page No. - 200)
14.1 Insights Of Industry Experts
14.2 Discussion Guide
14.3 Company Developments
14.3.1 Bio-Rad Laboratories, Inc. (U.S.)
14.3.2 F. Hoffmann-La Roche Ltd. (Switzerland)
14.3.3 Qiagen N.V. (Netherlands)
14.3.4 Raindance Technologies, Inc. (U.S.)
14.3.5 Thermo Fisher Scientific, Inc. (U.S.)
14.4 Introducing Rt: Real Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports